A detailed history of Mcf Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Mcf Advisors LLC holds 85 shares of NTRA stock, worth $14,636. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85
Previous 140 39.29%
Holding current value
$14,636
Previous $17,000 23.53%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$117.67 - $174.0 $6,471 - $9,570
-55 Reduced 39.29%
85 $13,000
Q1 2024

Apr 16, 2024

BUY
$59.21 - $92.9 $2,723 - $4,273
46 Added 48.94%
140 $12,000
Q4 2023

Feb 01, 2024

BUY
$37.55 - $62.64 $3,529 - $5,888
94 New
94 $5,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.